UFP Technologies, Inc. Research and Development Expense
UFP Technologies, Inc. (UFPT) reported Research and Development Expense of $8.60 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-02-27
- UFP Technologies, Inc. research and development expense for fiscal 2025 was $8.60M, a 17.31% decline from fiscal 2024.
- UFP Technologies, Inc. research and development expense for fiscal 2024 was $10.40M, a 44.44% increase from fiscal 2023.
- UFP Technologies, Inc. research and development expense for fiscal 2023 was $7.20M, a 22.58% decline from fiscal 2022.
- UFP Technologies, Inc. research and development expense for fiscal 2022 was $9.30M, a 9.41% increase from fiscal 2021.
| Period end | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed |
|---|---|---|
| 2025-12-31 | $8.60M 10-K · filed 2026-02-27 | |
| 2024-12-31 | $10.40M 10-K · filed 2026-02-27 | |
| 2023-12-31 | $7.20M 10-K · filed 2026-02-27 | |
| 2022-12-31 | $9.30M 10-K · filed 2025-03-03 | |
| 2021-12-31 | $8.50M 10-K · filed 2024-02-29 | |
| 2020-12-31 | $8.20M 10-K · filed 2023-03-16 | |
| 2019-12-31 | $8.80M 10-K · filed 2022-03-14 | $9.50M 10-K · filed 2020-03-13 |
| 2018-12-31 | $10.50M 10-K · filed 2021-03-12 | |
| 2017-12-31 | $5.00M 10-K · filed 2020-03-13 | $1.10M 10-K · filed 2018-03-16 |
| 2016-12-31 | $1.30M 10-K · filed 2018-03-16 | |
| 2015-12-31 | $1.30M 10-K · filed 2018-03-16 | $1.40M 10-K · filed 2016-03-11 |
| 2014-12-31 | $1.40M 10-K · filed 2017-03-10 | $1.20M 10-K · filed 2015-03-13 |
| 2013-12-31 | $1.20M 10-K · filed 2016-03-11 | |
| 2012-12-31 | $1.30M 10-K · filed 2015-03-13 | |
| 2011-12-31 | $1.20M 10-K · filed 2014-03-14 | |
| 2010-12-31 | $900.00K 10-K · filed 2013-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |